Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Hupperts, Raymond"" wg kryterium: Autor


Tytuł:
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial
Autorzy:
van der Walt, Anneke
Dwyer, Christopher
Buzzard, Katherine
Spies, Judith
Parratt, John
van Pesch, Vincent
Willekens, Barbara
Perrotta, Gaetano
Bartholomé, Emmanuel
Grand'Maison, Francois
Jacques, Francois
Giacomini, Paul
Vosoughi, Reza
Girard, Jean-Marc
de Seze, Jerome
Lebrun Frenay, Christine
Ruet, Aurelie
Laplaud, David-Axel
Reifschneider, Gerd
Wagner, Bert
Rauer, Sebastian
Pul, Refik
Seipelt, Maria
Berthele, Achim
Klotz, Luisa
Kallmann, Boris-Alexander
Paul, Friedemann
Achiron, Anat
Lus, Giacomo
Centonze, Diego
Patti, Francesco
Grimaldi, Luigi
Hupperts, Raymond
Frequin, Stephan
Fermont, Jiske
Madueno, Sara Eichau
Alonso Torres, Ana Maria
Costa-Frossard França, Lucienne
Meca-Lallana, Jose Eustasio
Ruiz, Luis Brieva
Pearson, Owen
Rog, David
Evangelou, Nikolaos
Ismail, Azza
Lathi, Ellen
Fox, Edward
Leist, Thomas
Sloane, Jacob
Wu, Gregory
Khatri, Bhupendra
Steingo, Brian
Thrower, Ben
Gudesblatt, Mark
Calkwood, Jonathan
Bandari, Daniel
Scagnelli, John
Laganke, Christopher
Robertson, Derrick
Kipp, Lucas
Belkin, Martin
Cohan, Stanley
Goldstick, Lawrence
Courtney, Ardith
Vargas, Wendy
Sylvester, Andrew
Srinivasan, Jayshri
Kannan, Meena
Picone, Maryann
English, Jeffrey
Napoli, Salvatore
Balabanov, Roumen
Zaydan, Islam
Nicholas, Jacqueline
Kaplan, Jeffrey
Lublin, Fred
Riser, Emily
Miller, Tamara
Alvarez, Enrique
Wray, Sibyl
Gross, Jeffrey
Pawate, Siddharama
Hersh, Carrie
McCarthy, Lucas
Crayton, Heidi
Graves, Jennifer
Foley, John F
Defer, Gilles
Ryerson, Lana Zhovtis
Cohen, Jeffrey A
Arnold, Douglas L
Butzkueven, Helmut
Cutter, Gary
Giovannoni, Gavin
Killestein, Joep
Wiendl, Heinz
Smirnakis, Karen
Xiao, Shan
Kong, George
Kuhelj, Robert
Campbell, Nolan
Pokaż więcej
Źródło:
In The Lancet Neurology July 2022 21(7):608-619
Czasopismo naukowe
Tytuł:
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
Autorzy:
Agüera Morales, Eduardo
Al Khedr, Abdullatif
Ampapa, Radek
Arroyo, Rafael
Belkin, Martin
Bonek, Robert
Boyko, Alexey
Capra, Ruggero
Centonze, Diego
Clavelou, Pierre
Debouverie, Marc
Drulovic, Jelena
Edwards, Keith
Evangelou, Nikos
Evdoshenko, Evgeniy
Fernández, Oscar
Fernández Sánchez, Victoria
Freedman, Mark
Freedman, Steven
Fryze, Waldemar
Garcia-Merino, Antonio
Gavric-Kezic, Mira
Ghezzi, Angel
Gout, Olivier
Grimaldi, Luigi
Hendin, Barry
Hertmanowska, Hanka
Hintzen, Rogier
Hradilek, Pavel
Hupperts, Raymond
Ilkowski, Jan
Ivashinenkova, Evelina
Izquierdo, Guillermo
Jacques, Francois
Jakab, Gabor
Khabirov, Farit
Klodowska-Duda, Gabriela
Komoly, Samuel
Kostic, Smiljana
Kovarova, Ivana
Kremenchuzky, Marcelo
Laganke, Christopher
LaPierre, Yves
Maciejowski, Maciej
Maison, Francois Grand
Marfia, Girolama Alessandra
Martínez Yélamos, Sergio
Meluzinova, Eva
Montalban, Xavier
Murray, Ronald
Naismith, Robert
Newsome, Scott
Nguyen, Viet
Oreja, Delia
Pardo, Gabriel
Pasechnik, Elena
Patti, Francesco
Potemkowski, Andrzej
Prokopenko, Semen
Qian, Peiqing
Rodríguez-Antigüedad, Alfredo
Rossman, Howard
Rozsa, Csilla
Sánchez López, Fernando
Selmaj, Krzysztof
Silber, Eli
Stepien, Adam
Stepniewska, Anna
Swiat, Maciej
Toncev, Gordana
Tourbah, Ayman
Trushnikova, Tatyana
Uccelli, Antonio
Vachova, Marta
Valis, Martin
Vecsei, Laszlo
Wiertlewski, Sandrine
Zaffaroni, Mauro
Zielinski, Tomasz
Cadavid, Diego
Mellion, Michelle
Edwards, Keith R
Calabresi, Peter A
Drulović, Jelena
Giovannoni, Gavin
Hartung, Hans-Peter
Arnold, Douglas L
Fisher, Elizabeth
Rudick, Richard
Mi, Sha
Chai, Yi
Li, Jie
Zhang, Yiwei
Cheng, Wenting
Xu, Lei
Zhu, Bing
Green, Susan M
Chang, Ih
Deykin, Aaron
Sheikh, Sarah I
Pokaż więcej
Źródło:
In The Lancet Neurology September 2019 18(9):845-856
Czasopismo naukowe
Tytuł:
Time to Qualifying Relapse by Previous Disease-Modifying Therapy Status in Patients with Relapsing Multiple Sclerosis Treated with Cladribine Tablets Over 2 Years in the CLARIFY-MS Study
Autorzy:
Patti, Francesco
Brochet, Bruno
Havrdová, Eva Kubala
Solari, Alessandra
Hupperts, Raymond
Langdon, Dawn
Lechner-Scott, Jeannette
Piehl, Fredrik
Selmaj, Krzysztof
Smyk, Andrzej
Lehn, Annette
Montalban, Xavier
Pokaż więcej
Źródło:
In Multiple Sclerosis and Related Disorders December 2023 80
Czasopismo naukowe
Tytuł:
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
Autorzy:
Bartholomé, Emmanuel
D'Hooghe, Marie
Pandolfo, Massimo
Van Wijmeersch, Bart
Bhan, Virender
Blevins, Gregg
Brunet, Donald
Devonshire, Virginia
Duquette, Pierre
Freedman, Mark
Grand'Maison, François
Jacques, François
Lapierre, Yves
Lee, Liesly
Morrow, Sarah
Yeung, Michael
Dufek, Michal
Havrdová, Eva Kubala
Kanovsky, Petr
Stetkarova, Ivana
Talabova, Marika
Frederiksen, Jette
Kant, Matthias
Petersen, Thor
Ravnborg, Mads
Sellebjerg, Finn
Airas, Laura
Elovaara, Irina
Eralinna, Juha-Pekka
Sarasoja, Taneli
Al Khedr, Abdullatif
Brassat, David
Brochet, Bruno
Camu, William
Debouverie, Marc
Laplaud, David
Lebrun Frenay, Christine
Pelletier, Jean
Vermersch, Patrick
Vukusi, Sandra
Baum, Karl
Berthele, Achim
Faiss, Juergen
Flachenecker, Peter
Hohlfeld, Reinhard
Krumbholz, Markus
Lassek, Christoph
Maeurer, Mathias
Meuth, Sven
Ziemssen, Tjalf
Hardiman, Orla
McGuigan, Christopher
Achiron, Anat
Karussis, Dimitrios
Bergamaschi, Roberto
Morra, Vincenzo Brescia
Comi, Giancarlo
Cottone, Salvatore
Grimaldi, Luigi
Mancardi, Giovanni Luigi
Massacesi, Luca
Nocentini, Ugo
Salvetti, Marco
Scarpini, Elio
Sola, Patrizia
Tedeschi, Gioacchino
Trojano, Maria
Zaffaroni, Mauro
Frequin, Stephan
Hupperts, Raymond
Killestein, Joep
Schrijver, Hans
Van Dijl, Ronald
van Munster, Erik
Czarnecki, Maciej
Drozdowski, Wieslaw
Fryze, Waldemar
Hertmanowska, Hanka
Ilkowski, Jan
Kaminska, Anna
Klodowska-Duda, Gabriela
Maciejowski, Maciej
Motta, Ewa
Podemski, Ryszard
Potemkowski, Andrzej
Rog, Teresa
Selmaj, Krzysztof
Stelmasiak, Zbigniew
Stepien, Adam
Tutaj, Andrzej
Zaborski, Jacek
Boyko, Alexey
Chefranova, Zanna
Evdoshenko, Evgeny
Khabirov, Farit
Sivertseva, Stella
Yakupov, Eduard
Alvarez Cermeño, Jose Carlos
Escartin, Antonio
Fernandez, Oscar Fernandez
Garcia-Merino, Antonio
Hernandez Perez, Miguel Angel
Ayuso, Guillermo Izquierdo
Lallana, José Meca
Gairin, Xavier Montalban
Oreja-Guevara, Celia
Saiz Hinarejos, Albert
Gunnarsson, Martin
Lycke, Jan
Martin, Claes
Piehl, Fredrik
Roshanisefat, Homayoun
Sundstrom, Peter
Duddy, Martin
Gran, Bruno
Harrower, Timothy
Hobart, Jeremy
Kapoor, Raju
Lee, Martin
Mattison, Paul
Nicholas, Richard
Pearson, Owen
Rashid, Waqar
Rog, David
Sharrack, Basil
Silber, Eli
Turner, Ben
Williams, Anna
Woolmore, John
Young, Carolyn
Bandari, Daniel
Berger, Joseph
Camac, Ann
Cohan, Stanley
Conway, Jill
Edwards, Keith
Fabian, Michelle
Florin, Jack
Freedman, Steven
Garwacki, Dennis
Goldman, Myla
Harrison, Daniel
Herrman, Craig
Huang, Deren
Javed, Adil
Jeffery, Douglas
Kamin, Stephen
Katsamakis, George
Khatri, Bhupendra
Langer-Gould, Annette
Lynch, Sharon
Mattson, David
Miller, Tamara
Miravalle, Augusto
Moses, Harold
Muley, Suraj
Napier, James
Nielsen, Allen
Pachner, Andrew
Pardo, Gabriel
Picone, MaryAnn
Robertson, Derrick
Royal, Walter
Sheppard, Christopher
Thrower, Ben
Twyman, Cary
Waubant, Emmanuelle
Wendt, Jeanette
Yadav, Vijayshree
Zabad, Rana
Zarelli, Greg
Ho, Pei-Ran
Campbell, Nolan
Chang, Ih
Deykin, Aaron
Forrestal, Fiona
Lucas, Nisha
Yu, Bei
Arnold, Douglas L
Freedman, Mark S
Goldman, Myla D
Hartung, Hans-Peter
Miller, Aaron
Cadavid, Diego
Mikol, Dan
Steiner, Deborah
Pokaż więcej
Źródło:
In The Lancet Neurology May 2018 17(5):405-415
Czasopismo naukowe
Tytuł:
Improvements in Quality of Life Over 2 Years in Patients Treated with Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: Final Analysis of CLARIFY-MS
Autorzy:
Solari, Alessandra
Montalban, Xavier
Lechner-Scott, Jeannette
Piehl, Fredrik
Brochet, Bruno
Langdon, Dawn
Hupperts, Raymond
Selmaj, Krzysztof
Havrdova, Eva K.
Patti, Francesco
Brieva, Luis
Maida, Eva Maria
Alexandri, Nektaria
Smyk, Andrzej
Nolting, Axel
Keller, Birgit
on behalf of the CLARIFY-MS Investigators
Pokaż więcej
Źródło:
In Multiple Sclerosis and Related Disorders March 2023 71
Czasopismo naukowe
Tytuł:
Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine
Autorzy:
Hobart, Jeremy
Ziemssen, Tjalf
Feys, Peter
Linnebank, Michael
Goodman, Andrew D.
Farrell, Rachel
Hupperts, Raymond
Blight, Andrew R.
Englishby, Veronica
McNeill, Manjit
Chang, Ih
Lima, Gabriel
Elkins, Jacob
On behalf of the ENHANCE study investigators
Pokaż więcej
Źródło:
CNS Drugs. 33(1):61-79
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies